Pharmacy Policy Updates for August 2025
Alabama Sets Minimum PBM Reimbursement Rate In April 2025, Alabama lawmakers passed legislation (unanimously via a 102-0 House…
FDA Issues CRL to Replimune for Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma
The FDA issued a complete response letter (CRL) for the biologics application for vusolimogene oderparepvec (RP1; Replimune Group,…
How AI Brings Pharmacogenetics to the Frontline of Precision Medicine
A man aged 55 years with metastatic colorectal cancer was initiated on a standard fluoropyrimidine-based chemotherapy regimen. Within…
Recommendations From Health Care Professionals Improve Immunization Rates Among Patients With CKD
Both influenza and pneumococcus vaccination rates in patients with chronic kidney disease (CKD) are below established targets, wrote…